This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Richter Gedeon Nyrt.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by József Levente Petró
Introduction
József Levente Petró is a notable inventor based in Szazhalombatta, Hungary. He has made significant contributions to the field of pharmacology through his innovative work on pyrazolo[1,5-a]pyrimidine derivatives. His research focuses on developing compounds that serve as GABAB receptor positive allosteric modulators, which have potential therapeutic applications.
Latest Patents
József Levente Petró holds 1 patent for his invention titled "Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives." This invention relates to new pyrazolo[1,5-a]pyrimidine derivatives or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates, and hydrates. These compounds are designed to modulate the GABAB receptor positively, which is crucial for treating various diseases and conditions.
Career Highlights
József Levente Petró is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to contribute to the development of innovative pharmaceutical solutions. His research has implications for the treatment of disorders mediated by the GABAB receptor.
Collaborations
Throughout his career, József has collaborated with notable colleagues such as Gyula Attila Bényei and János Éles. These collaborations have enhanced the scope and impact of his research in the pharmaceutical field.
Conclusion
József Levente Petró's contributions to pharmacology through his innovative inventions highlight the importance of research in developing new therapeutic agents. His work continues to influence the field and offers promising avenues for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
